aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded with a mission to innovate healthcare, RK Pharma specializes in the development and manufacturing of high-quality pharmaceutical ingredients and generic products. The company aims to address formulation challenges and provide affordable medication options. Their product lineup includes diclofenac potassium tablets, mycophenolic acid DR tablets, and mitomycin injection vials, among others. RK Pharma focuses on the healthcare market, particularly on products that require unique formulation solutions.
RK Pharma has established itself as a significant player in the pharmaceutical industry through its integrated development, regulatory, and manufacturing capabilities. The company collaborates with various drug product partnerships to enhance its market reach. Notable achievements include the successful commercialization of several complex generic medications. By providing cost-effective and high-quality pharmaceutical solutions, RK Pharma has made a substantial impact on improving patient access to essential medications.
Operating Status
Active
Ownership Type(s)
Private
Main Product(s)
Pharmaceuticals, Generics
Tags
Pharmaceuticals
Model Types
Manufacturing, Software
Revenue Type(s)
Transactional, Recurring
Customer Type(s)
Enterprise, Healthcare
Geographic Exposure
Global
When was R K Pharma founded?
R K Pharma was founded in 2018.
Where is R K Pharma’s headquarters located?
R K Pharma’s headquarters is located in NJ, US.
When was R K Pharma’s last funding round?
R K Pharma’s most recent funding round was for $200M (USD) in June 2023.
How many employees does R K Pharma have?
R K Pharma has 1001 employees as of Feb 4, 2024.
How much has R K Pharma raised to-date?
As of July 05, 2023, R K Pharma has raised a total of $200M (USD) since Jun 6, 2023.
Add Comparison
Total Raised to Date
$200M
USD
Last Update Jun 6, 2023
Last Deal Details
$200M
USD
Jun 6, 2023
Private Equity
Total Employees Over Time
1001
As of Feb 2024
R K Pharma Address
New Jersey
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts